DE

News & Events

News & Events

• Press Releases
• In the Media
• Events
• Publications

Publications

ARTICLES

A Novel Chemical Entity, that Reverses Warburg Metabolism by Disrupting VDAC1/HK2 Interaction through “Toposteric Effect” in Cancer

 

A Hexokinase 2 Modulator for Field-Directed Treatment of Experimental Actinic Keratoses. 

 

Max Herzberg: A case study in cancer research
Protein mislocation in cancer

 

 

POSTERS

 

SITC 2018:

Modulating Hexokinase 2 (HK2) as a Novel Approach for Simultaneous Targeting of the Tumor and Its Immunosuppressive Microenvironment

 

  

Fall Clinical Dermatology Conference ® 2018

A Novel Well-Tolerated Treatment for Actinic Keratosis. 

 

AACR 2018:

Activating the NLRP3 Inflammasome in Macrophages and Triggering Apoptosis in Cancer Cells via HK2/VDAC Modulator. 

 

 

 

LiveSites | Login

© 2016 - 2025 Vidac

To Top